Navigation Links
West Pharmaceutical Services Announces Third Quarter 2007 Results
Date:11/1/2007

- Sales up 11.2% and Earnings Per Diluted Share up 20% Excluding Tax Items

- - Expects to Earn $0.46 to $0.50 per Diluted Share in the Fourth Quarter -

- Conference Call to be held at 9 a.m. EDT Today -

LIONVILLE, Pa., Nov. 1 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the results of operations for the three and nine months ended September 30, 2007, reporting earnings of $0.36 per diluted share in the third quarter, including certain tax items. Summary non-GAAP consolidated results for the third quarter, which are adjusted to exclude the net tax charges of $2.3 million, or $0.06 per diluted share, were as follows:

Three Months Ended

September 30 %

($ millions, except per-share data ) 2007 2006 Change

Net Sales $242.7 $218.4 11.2 %

Gross Profit 64.3 59.5 8.1 %

Adjusted Operating Profit 21.5 19.7 9.1 %

Adjusted Diluted EPS $0.42 $0.35 20.0 %

A table accompanying this press release contains a reconciliation of results reported under US GAAP and the non-GAAP results included above, which are provided, in addition to and not as a substitute for, the reported GAAP results. The excluded items relate to changes to the Company's expectations regarding several prior-year tax contingencies.

"Our year-to-date and quarterly results reflect the fundamental strength in our packaging and delivery systems busines
'/>"/>

SOURCE West Pharmaceutical Services, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...ug. 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (N...ors declared a regular,quarterly cash dividend of ...008. The dividend will be paid on October 3, 2008,... About Landauer, Landauer is the leading provide... and environmental radiation exposure. For more th...
(Date:8/29/2008)...fic obligation reduced from $250 to $19 million, ...oston Scientific,Corporation (NYSE: BSX ) today a... Texas found two patents of Medtronic, Inc. (NYSE:...ng the prosecution of the patents,before the Unite... previously found that certain Boston Scientific b...
(Date:8/29/2008)... Dr. Milton Owens and the Coastal Center for O...ia to provide protection for cash paying patients ...ic community is benefiting. , .... Milton Owens and the Coastal Center for Obesity ...rovide protection for cash paying patients in the ...
(Date:8/29/2008)... Trusted life science software provider allows...ngage via GSA. , Reston, ...erging software engineering firm dedicated to the...ral Services Administration (GSA) Contract. The GS...h the ability to conveniently engage 5AM Solutions...
Breaking Medicine News(10 mins):Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2
...occus Aureus) is a bacteria resistant to certain a...ients who suffer //from weakened immune systems, e...own to spread because of poor hygiene. Countries l...ay, where MRSA has been relatively low and stable ...
...an children with AIDS, five Bulgarian Nurses and a...sion //in the Court of Appellations in Tripoli. ...pital aids made the outbreak possible since all th...ive results. But the Libyan authorities refused th...
...ng various opinions on the issue of doctors being ...atients //without fear of a ban. In its new draf... careful and remind them that the relationship wou...appropriate. In a move that nullifies the past p...
...rsity School of Medicine and colleagues finds it’s...lt medical procedures //about the dizzy feel of na...trongly affect how they respond to adversity – bot...d lead author Max E. Levine, Ph.D. ‘Being prepared...
Other Medicine News:Health News:Super-bug MRSA Getting Fitter And Out of Control 2Health News:Precautious Measure Help Tolerate Nausea In Patients 2Health News:Precautious Measure Help Tolerate Nausea In Patients 3
(Date:8/27/2008)...Spraying Set for Tonight in Parts of Bucks, Delawa..., Pa., Aug. 27 /PRNewswire-USNewswire/ -- After en...ial treatments, the Department of,Environmental Pr... protect,the public against the mosquito-borne Wes... administered between 8 p.m. and,midnight in porti...
(Date:8/27/2008)...rd Winning Research Team Makes Crucial Breakthroug...of Parkinson,s Disease, CHICAGO, Aug. 27 /PRNewsw...on today announced that scientists at The Universi...in the battle to slow or prevent the onset,of a ve...., The researchers have genetically produced the ...
(Date:8/27/2008)... - First Phase 3 data, from BLISS-52 trial, expec...l, BLISS-76, expected by fall 2009 -, ROCKVILLE, ...e,Sciences, Inc. (Nasdaq: HGSI ) today announced ...BLISS-76, the second of two pivotal Phase 3,random...) in patients with,active systemic lupus erythemat...
(Date:8/26/2008)... INDIANAPOLIS, Aug. 26 /- Semafore Ph... Seventh International Congress on Targeted,Therap...nal antiangiogenic,activity of vascular-targeted P...h VEGF and Bv8 signaling., PI3K is part of a very...has been shown to play a major role in cancer. Stu...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Surprise U S Supreme Court Decision Helps Michigan Citizens 13313 1mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 1mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 2mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 3mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 4mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 5mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 6RealSelf com Denies Lifestyle Lifts Trademark Claims and Files Countersuit 13307 1RealSelf com Denies Lifestyle Lifts Trademark Claims and Files Countersuit 13307 2Beauty com Partners With Fashion Designer Jenni Kayne 13304 1Beauty com Partners With Fashion Designer Jenni Kayne 13304 2Beauty com Partners With Fashion Designer Jenni Kayne 13304 3Beauty com Partners With Fashion Designer Jenni Kayne 13304 4
...Family History of ESRD Are at High,Risk , ,WASHIN...f U.S.,adults have a family history of end-stage r...to be at increased risk of developing,kidney disea...l of,the American Society of Nephrology. , "A fami...frican-Americans, who are also at substantially hi...
...ibody significantly reduced the number of,new or e...bmitted,for presentation at upcoming medical meeti...12, 2007,/PRNewswire-FirstCall/ -- Biogen Idec, In...hat the ongoing CHOICE trial, a Phase 2,randomize...zumab,met its primary endpoint in relapsing multi...
Other Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 4Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 5
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...ELISA products make us a leader in this field. Wit...into the busy laboratory, our Infectious Disease E...n-to-run consistency. Our Infectious Disease ELISA...e range of serological assays including ToRCH, EBV...
Medicine Products: